Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT07040423
Starting soon Not applicable

MRI-Based Assessment of Local Anesthetic Spread in the PENG Block Compartment

NCT07040423 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2025-06
Last updated
2025-06-27

Condition(s) studied

Total Hip Arthroplasty (THA)Postoperative Pain Management After Total Hip Arthroplasty

Investigational drug(s) / intervention(s)

PENG BlockMagnetic resonance imaging

PENG Block: Preoperative ultrasound giuded PENG block (ropivacaine 0,5% 20mL)

Magnetic resonance imaging: The patient will undergo a pelvic MRI to assess anesthetic diffusion after PENG block

Study summary

This study uses MRI imaging to evaluate the spread of local anesthetic following the administration of a pericapsular nerve group (PENG) block. The goal is to determine whether a distinct fascial plane exists between neurovascular structures, potentially explaining the block's observed clinical effectiveness.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients scheduled for total hip replacement surgery * Age ≥ 18 years * ASA physical status classification I-III * Signed informed consent obtained * Orthopedic indication for preoperative MRI study Exclusion Criteria: * Allergy to local anesthetics * Infection at the planned puncture site * Refusal or inability to provide informed consent * Age \< 18 years * Claustrophobia * Altered consciousness or severe dementia * Presence of MRI-incompatible implanted devices (e.g., pacemakers implanted before 2000) * Pregnancy or breastfeeding

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Policlinico Universitario Campus Bio-Medico Roma Italy

More Campus Bio-Medico University trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07040423 on ClinicalTrials.gov ↗ ← All trials in Italy